Biological tissues have a remarkable ability to organize and change shape, driven by forces generated by their own cells. One ...
(Nanowerk News) By simulating the life cycle of a minimal bacterial cell — from DNA replication to protein translation to metabolism and cell division — scientists have opened a new frontier of ...
Nationwide Mammographic Screening Among a Large Population of Underserved Subgroups Between April 4, 2023, and December 26, 2024, 43 patients were screened, 40 were enrolled, and 36 received infusion ...
Menstrual cycle phases affect every aspect of your being—mind, body, and emotions. So why not choose a yoga flow that meets you where you are? Paying attention to your energy levels and needs as well ...
The G2 Austin facility is a US$400-425 million investment, at which T1 expects to begin commercial operation by the end of 2026. Image: T1 Energy. US solar manufacturer T1 Energy has started ...
The ongoing phase I/II clinical trial is evaluating the safety, tolerability and early efficacy signals of Aleta’s first-in-class biologic CAR T-cell engager, ALETA-001 Preliminary findings include a ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The allogenic cell therapy achieved all primary and ...
Is it that time of the month? The one where your heating pad becomes your best friend and the thought of working out feels like a joke? We’ve all been there. But here’s the plot twist: moving your ...
CRD-750 is the first clinical-stage PDE9 inhibitor to be evaluated in patients in both types of chronic heart failure The CYCLE-1-REF trial is evaluating patients with heart failure with reduced ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Exicure, Inc. (Nasdaq: XCUR), a clinical-stage biotechnology company developing therapeutics for hematologic diseases, today announced it has completed the last ...
Adicet Bio is handing out pink slips to 30% of its staffers in tandem with a pipeline restructure that includes discontinuing a clinical-stage allogeneic cell therapy. The layoffs are expected to be ...
Rajeev Dhir is a writer with 10+ years of experience as a journalist with a background in broadcast, print, and digital newsrooms. Betsy began her career in international finance and it has since ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results